S013 Comprehensive Hair Restoration using Surgical and Non-surgical Technologies
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
The hair restoration course was specifically designed for physicians looking to incorporate new hair loss technologies and combination therapies into their practice. The advancements and newer technologies (lasers/light/RF), injection therapy procedures (PRP, exosomes), and combination drug therapies allow for regrowth of hair sometimes facilitated by the next generation technologies in hair transplantation.
LEARNING OBJECTIVES
Describe how an understanding of hair biology may lead to new therapies.
Review the latest developments in molecular regulation of hair follicle function and discuss their relevance to clinical practice.
Discuss the latest hair loss medications in clinical trials, the mechanism of action of energy-based devices and the regenerative treatments for hair regrowth.
SCHEDULE
6:00 PM
Evidence based approaches to PRP protocols
6:10 PM
Excimer laser and microneedling for treatment of hair loss
Divya Sharma, MD, FAAD
6:20 PM
Decision Making Strategies in the Treatment of Hair Loss
Maria K. Hordinsky, MD, FAAD
6:30 PM
FAPD (Fibrosing Alopecia in a pattern distribution) or AGA with inflamation? Two entities that need to be differentiated before a hair transplant
Maria F. R. Gavazzoni Dias, MD, IFAAD
6:40 PM
photobiomodulation therapy for hair loss: MOA how I employ it in my multi-modality hair loss program
Ronda S. Farah, MD, FAAD
6:50 PM
MEsotherapy and hair loss, treatments for alopecia
7:10 PM
Topical products for hair growth'
Matt L. Leavitt, DO, FAAD
7:20 PM
Regenerative treatment for hair
Neil S. Sadick, MD, FAAD
7:30 PM
Unlocking the potential and evidence: exosome biology in hair regeneration
Saranya P. Wyles, MD, PhD
7:40 PM
Unraveling the history of exosomes
Jeffrey A. Rapaport, MD, FAAD
7:50 PM
FUE donor issues
Paul T. Rose, MD, FAAD
8:00 PM
Differentiating PRP treatments
8:10 PM
Best technique for hair transplantation surgery
Marc R. Avram, MD, FAAD
8:20 PM
Q&A
SPEAKERS
Marc R. Avram, MD, FAAD
Ronda S. Farah, MD, FAAD
Maria F. R. Gavazzoni Dias, MD, IFAAD
Maria K. Hordinsky, MD, FAAD
Matt L. Leavitt, DO, FAAD
Jeffrey A. Rapaport, MD, FAAD
Paul T. Rose, MD, FAAD
Neil S. Sadick, MD, FAAD
Javed Shaik
Saranya P. Wyles, MD, PhD
HANDOUTS
SPEAKER DISCLOSURES
Marc R. Avram, MD, FAAD
Lumenis Be Ltd. – Consultant (1099 relationship)(Honoraria);
Ronda S. Farah, MD, FAAD
American Academy of Dermatology – Other(Grants/Research Funding); Arcutis, Inc. – Investigator(Grants/Research Funding); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Early Sullivan Wright Gizer & McRae LLP – Consultant (1099 relationship)(Fees); Eli Lilly – Investigator(Grants/Research Funding); Lumenis Be Ltd. – Consultant (1099 relationship)(Fees); Novartis – Advisory Board(Fees); Pfizer – Investigator(Grants/Research Funding); Pfizer Inc. – Stockholder(No Compensation Received), Stockholder Public Company(No Compensation Received); Technoderma Medicines – Investigator(Grants/Research Funding);
Maria F. R. Gavazzoni Dias, MD, IFAAD
No financial relationships exist with ineligible companies.
Maria K. Hordinsky, MD, FAAD
AbbVie – Advisory Board(Fees); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Cassiopea – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); National Alopecia Areata Foundation – Investigator(Grants/Research Funding); RegenLab – Investigator(Grants/Research Funding); Sun Pharmaceuticals – Investigator(Grants/Research Funding); UpToDate, Inc – Other(Fees);
Matt L. Leavitt, DO, FAAD
Eli Lilly and Company – Advisory Board(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria); Tieman Surgical Instruments – Other(Patent royalties or other compensation for Intellectual Property Rights); Xtresse – Founder(No Compensation Received);
Jeffrey A. Rapaport, MD, FAAD
Crown Laboratories, Inc. – Consultant(Fees);
Paul T. Rose, MD, FAAD
No financial relationships exist with ineligible companies.
Neil S. Sadick, MD, FAAD
AbbVie – Consultant(Fees); Aclaris Therapeutics Inc. – Investigator(Grants/Research Funding); Acorn Biolabs – Speaker(Honoraria); Advalight – Investigator(Grants/Research Funding), Speaker(Honoraria); Allergan, Inc. – Consultant(Honoraria); Alma Lasers, Inc. – Investigator(Equipment), Investigator(Grants/Research Funding); American Academy of Dermatology – Speaker(No Compensation Received); American Hair Research Society – Board of Directors(No Compensation Received); American Society of Dermatologic Surgery – Speaker(No Compensation Received); Amgen – Investigator(Grants/Research Funding); ASLAN – Investigator(Grants/Research Funding); Aurigene Discovery Technologies Ltd – Independent Contractor(Grants/Research Funding); Bausch Health – Investigator(Grants/Research Funding); Bellus Health – Investigator(Grants/Research Funding); Biorasi, LLC – Investigator(Grants/Research Funding); Biosion – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Canfield Scientific, Inc. – Other(Equipment); Cara Therapeutics – Investigator(Grants/Research Funding); Castle Biosciences – Investigator(Grants/Research Funding); Cell Research Corp – Consultant (1099 relationship)(Honoraria); Celldex – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Corvus Pharmaceuticals – Investigator(Grants/Research Funding); Cutera, Inc. – Other(Equipment), Speaker(Honoraria); Derm Advance – Stockholder(Stock Options); Derm Tech International – Consultant(Fees), Investigator(Grants/Research Funding); Dermira – Investigator(Grants/Research Funding); Distinct Dermatology – Stockholder Private Company(Stock Options); Dr Reddy's Laboratory – Investigator(Grants/Research Funding); Eirion Therapeutics – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); EndyMed Medical Inc. USA – Speaker(Honoraria); Fortrea – Investigator(No Compensation Received); Foundation for Research & Education of Dermatology – Advisory Board(Honoraria), Speaker/Faculty Education(Fees); Galderma USA – Investigator(Grants/Research Funding); Gerson Lehrman Group – Consultant(Honoraria); GlaxoSmithKline Immunology – Investigator(Grants/Research Funding); Highlightll Pharmaceutical – Investigator(Grants/Research Funding); ICON plc. – Investigator(No Compensation Received); IMCAS – Speaker/Faculty Education(Honoraria), Speaker/Faculty Education(Other Financial Benefit); Incyte Corporation – Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); Innovaderm Research Inc. – Investigator(No Compensation Received); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); Kimera Labs, Inc – Speaker(Honoraria); L'Oreal USA Inc. – Advisory Board(Fees), Consultant (1099 relationship)(Fees); LCN Consulting – Consultant(Fees); LEO Laboratories Ltd (LEO Pharma) – Investigator(Grants/Research Funding); Lumenis Be Ltd. – Consultant(Fees), Investigator(Grants/Research Funding); Lumisque – Speaker(Honoraria); Meiji Seika Pharma Co., Ltd – Investigator(Grants/Research Funding); Merz Aesthetics – Investigator(Grants/Research Funding); Nektar Therapeutics – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); NFlection Therapeutics, Inc – Investigator(Grants/Research Funding); NUMAB Therapeutics AG – Investigator(Grants/Research Funding); Paraxel Therapeutics, Inc – Investigator(No Compensation Received); Pfizer Inc. – Investigator(Grants/Research Funding); PPD Inc. – Investigator(Grants/Research Funding); Rho Inc. – Investigator(Grants/Research Funding); Sanofi – Investigator(Equipment), Investigator(Grants/Research Funding); Scientus Pharma Inc. – Stockholder(Stock Options); Shaperon – Investigator(Equipment), Investigator(Grants/Research Funding); Syneos Health – Investigator(No Compensation Received); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding); Taylor & Francis – Other(Other Financial Benefit); UCB – Investigator(Equipment), Investigator(Grants/Research Funding); Union Therapeutics – Investigator(Grants/Research Funding); Venus Concept – Investigator(Grants/Research Funding), Other(Equipment), Stockholder(Stock Options); VeraDermics Inc. – Investigator(Grants/Research Funding); Vial – Investigator(No Compensation Received); Vydence Medical – Other(Equipment), Speaker(Honoraria); WeThrivv – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria), Stockholder Private Company(Stock Options);
Javed Shaik
No financial relationships exist with ineligible companies.
Saranya P. Wyles, MD, PhD
Allergan Aesthetics – Consultant(Grants/Research Funding); Lumisque – Investigator(Grants/Research Funding); Rapalogix Health – Consultant (1099 relationship)(Fees); Rion Aesthetics – Consultant (1099 relationship)(Fees);